190 related articles for article (PubMed ID: 17017547)
41. [Pathophysiological process underlying Parkinson's disease: motor & non-motor symptoms].
Takeda A; Baba T; Kikuchi A; Sugeno N; Hasegawa T; Itoyama Y; Ishioka T; Hirayama K; Mori E
Rinsho Shinkeigaku; 2009 Nov; 49(11):888-9. PubMed ID: 20030239
[TBL] [Abstract][Full Text] [Related]
42. [Presymptomatic detection of Parkinson's disease].
Berendse HW; Booij J; Stoffers D; Ponsen MM; Hijman R; Wolters ECh
Tijdschr Gerontol Geriatr; 2002 Apr; 33(2):70-7. PubMed ID: 12012945
[TBL] [Abstract][Full Text] [Related]
43. Olfactory dysfunctions in drug-naïve Parkinson's disease with mild cognitive impairment.
Park JW; Kwon DY; Choi JH; Park MH; Yoon HK
Parkinsonism Relat Disord; 2018 Jan; 46():69-73. PubMed ID: 29233469
[TBL] [Abstract][Full Text] [Related]
44. Hyposmia and executive dysfunction as predictors of future Parkinson's disease: a prospective study.
Ponsen MM; Stoffers D; Twisk JW; Wolters ECh; Berendse HW
Mov Disord; 2009 May; 24(7):1060-5. PubMed ID: 19353591
[TBL] [Abstract][Full Text] [Related]
45. Olfaction in Parkinson's disease: methods of assessment and clinical relevance.
Liberini P; Parola S; Spano PF; Antonini L
J Neurol; 2000 Feb; 247(2):88-96. PubMed ID: 10751109
[TBL] [Abstract][Full Text] [Related]
46. Hyposmia in a simple smell test is associated with accelerated cognitive decline in early Parkinson's disease.
Gjerde KV; Müller B; Skeie GO; Assmus J; Alves G; Tysnes OB
Acta Neurol Scand; 2018 Dec; 138(6):508-514. PubMed ID: 30058142
[TBL] [Abstract][Full Text] [Related]
47. Mitral cells and the glucagon-like peptide 1 receptor: The sweet smell of success?
Bagnoli E; FitzGerald U
Eur J Neurosci; 2019 Feb; 49(4):422-439. PubMed ID: 30120857
[TBL] [Abstract][Full Text] [Related]
48. Alterations in the limbic/paralimbic cortices of Parkinson's disease patients with hyposmia under resting-state functional MRI by regional homogeneity and functional connectivity analysis.
Su M; Wang S; Fang W; Zhu Y; Li R; Sheng K; Zou D; Han Y; Wang X; Cheng O
Parkinsonism Relat Disord; 2015 Jul; 21(7):698-703. PubMed ID: 25937615
[TBL] [Abstract][Full Text] [Related]
49. Striatal dopamine uptake and olfactory dysfunction in patients with early Parkinson's disease.
Oh YS; Kim JS; Hwang EJ; Lyoo CH
Parkinsonism Relat Disord; 2018 Nov; 56():47-51. PubMed ID: 29925486
[TBL] [Abstract][Full Text] [Related]
50. Risk factors for Parkinson's disease and impaired olfaction in relatives of patients with Parkinson's disease.
Siderowf A; Jennings D; Connolly J; Doty RL; Marek K; Stern MB
Mov Disord; 2007 Nov; 22(15):2249-55. PubMed ID: 17876851
[TBL] [Abstract][Full Text] [Related]
51. Distinctive Olfactory Pattern in Parkinson's Disease and Non-Neurodegenerative Causes of Hyposmia.
Crespo Cuevas AM; Ispierto L; Vilas D; Planas A; Planas A; Isern I; Sanchez J; De Haro J; Alvarez R
Neurodegener Dis; 2018; 18(2-3):143-149. PubMed ID: 29940577
[TBL] [Abstract][Full Text] [Related]
52. COVID-19 and Parkinson's disease: Defects in neurogenesis as the potential cause of olfactory system impairments and anosmia.
Rethinavel HS; Ravichandran S; Radhakrishnan RK; Kandasamy M
J Chem Neuroanat; 2021 Sep; 115():101965. PubMed ID: 33989761
[TBL] [Abstract][Full Text] [Related]
53. Potential convergence of olfactory dysfunction in Parkinson's disease and COVID-19: The role of neuroinflammation.
Li H; Qian J; Wang Y; Wang J; Mi X; Qu L; Song N; Xie J
Ageing Res Rev; 2024 Jun; 97():102288. PubMed ID: 38580172
[TBL] [Abstract][Full Text] [Related]
54. Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT.
Sommer U; Hummel T; Cormann K; Mueller A; Frasnelli J; Kropp J; Reichmann H
Mov Disord; 2004 Oct; 19(10):1196-202. PubMed ID: 15390014
[TBL] [Abstract][Full Text] [Related]
55. Ablation of tau causes an olfactory deficit in a murine model of Parkinson's disease.
Beauchamp LC; Chan J; Hung LW; Padman BS; Vella LJ; Liu XM; Coleman B; Bush AI; Lazarou M; Hill AF; Jacobson L; Barnham KJ
Acta Neuropathol Commun; 2018 Jul; 6(1):57. PubMed ID: 29976255
[TBL] [Abstract][Full Text] [Related]
56. Lateralized microstructural changes in early-stage Parkinson's disease in anterior olfactory structures, but not in substantia nigra.
Joshi N; Rolheiser TM; Fisk JD; McKelvey JR; Schoffer K; Phillips G; Armstrong M; Khan MN; Leslie RA; Rusak B; Robertson HA; Good KP
J Neurol; 2017 Jul; 264(7):1497-1505. PubMed ID: 28653210
[TBL] [Abstract][Full Text] [Related]
57. Association of olfactory dysfunction and brain. Metabolism in Parkinson's disease.
Baba T; Takeda A; Kikuchi A; Nishio Y; Hosokai Y; Hirayama K; Hasegawa T; Sugeno N; Suzuki K; Mori E; Takahashi S; Fukuda H; Itoyama Y
Mov Disord; 2011 Mar; 26(4):621-8. PubMed ID: 21284041
[TBL] [Abstract][Full Text] [Related]
58. Hippocampal volume is related to olfactory impairment in Parkinson's disease.
Roh H; Kang J; Koh SB; Kim JH
J Neuroimaging; 2021 Nov; 31(6):1176-1183. PubMed ID: 34355455
[TBL] [Abstract][Full Text] [Related]
59. Impaired cholinergic transmission in patients with Parkinson's disease and olfactory dysfunction.
Versace V; Langthaler PB; Sebastianelli L; Höller Y; Brigo F; Orioli A; Saltuari L; Nardone R
J Neurol Sci; 2017 Jun; 377():55-61. PubMed ID: 28477708
[TBL] [Abstract][Full Text] [Related]
60. Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3 year longitudinal study.
Baba T; Kikuchi A; Hirayama K; Nishio Y; Hosokai Y; Kanno S; Hasegawa T; Sugeno N; Konno M; Suzuki K; Takahashi S; Fukuda H; Aoki M; Itoyama Y; Mori E; Takeda A
Brain; 2012 Jan; 135(Pt 1):161-9. PubMed ID: 22287381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
